Finance

Beta
Lists
ONESOURCE:NSE
Onesource Specialty Pharma Ltd
₹1,625.00
-0.04%
(-0.70) 1D
Jul 10, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ONESOURCE...
Open
₹1,626.10
High
₹1,650.00
Low
₹1,506.10
Mkt. cap
186.34B
Avg. vol.
243.33K
Volume
960.51K
52-wk high
₹2,088.00
52-wk low
₹1,057.00
EPS
-₹6.44
No. of employees
1K
Open
₹1,626.10
High
₹1,650.00
Low
₹1,506.10
Mkt. cap
186.34B
Avg. vol.
243.33K
Volume
960.51K
52-wk high
₹2,088.00
52-wk low
₹1,057.00
EPS
-₹6.44
No. of employees
1K
News stories
From sources across the web
About Onesource Specialty Pharma Ltd
CEO-
Employees1.41K
Founded2007
Headquarters-
SectorHealth care
Websiteonesourcecdmo.com
Last report
May 13, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
4.28B / 3.57B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.27B
3.76B
2.90B
4.28B
Cost of goods sold
929.19M
1.13B
943.66M
1.46B
Cost of revenue
929.19M
1.13B
943.66M
1.46B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
584.38M
628.21M
641.92M
627.42M
Operating expense
2.14B
2.26B
2.48B
2.62B
Total operating expenses
3.07B
3.39B
3.43B
4.08B
Operating income
206.81M
366.68M
-523.15M
200.95M
Other non operating income
52.68M
30.36M
46.25M
20.93M
EBT including unusual items
-43.99M
57.41M
-930.11M
-2.92M
EBT excluding unusual items
-15.29M
57.41M
-859.21M
-3.25M
Income tax expense
-42.13M
-47.44M
-43.12M
-48.89M
Effective tax rate
95.77%
-82.63%
4.64%
1,674.32%
Other operating expenses
874.29M
929.57M
1.14B
1.27B
Net income
-1.86M
104.85M
-886.99M
45.97M
Net profit margin
-0.06%
2.79%
-30.55%
1.07%
Earnings per share
-
-
-7.15
-
Interest and investment income
-
-
-
-
Interest expense
-274.78M
-339.63M
-382.31M
-225.13M
Net interest expenses
-274.78M
-339.63M
-382.31M
-225.13M
Depreciation and amortization charges
678.03M
698.27M
696.37M
718.26M
EBITDA
891.52M
1.05B
92.24M
898.68M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer